Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Showing 581 - 590 of 596 results

First page
Previous page
59
Next page
Next page

MIPOMERSEN SODIUM

18EAY4870E

Sequence Search

Status:

US Previously Marketed

Source:

KYNAMRO by KASTLE THERAPS LLC

(2013)

Source URL:

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203568

First approved in 2013

Source:

KYNAMRO by KASTLE THERAPS LLC

Source URL:

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203568

Class:

NUCLEIC ACID

POLYQUATERNIUM-10 (20000 MPA.S AT 2%)

N2GK4S7X4T

Status:

Possibly Marketed Outside US

Source:

21 CFR 333D

(2014)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=91dcaea1-bb34-484b-9798-94dd4e0aa49b

First approved in 2013

Source:

21 CFR 333A

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=959d1525-2681-4912-9711-fa2c4a5b152d

Class:

POLYMER

INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED)

WD5E5VYM2E

Status:

Possibly Marketed Outside US

Source:

BLA103914

(2013)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8213c229-a67a-4d3f-bd8f-b8729ae28472

First approved in 2013

Source:

BLA103914

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8213c229-a67a-4d3f-bd8f-b8729ae28472

Class:

STRUCTURALLY DIVERSE

INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED)

FF9YP4D23C

Status:

Possibly Marketed Outside US

Source:

BLA103914

(2013)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8213c229-a67a-4d3f-bd8f-b8729ae28472

First approved in 2013

Source:

BLA103914

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8213c229-a67a-4d3f-bd8f-b8729ae28472

Class:

STRUCTURALLY DIVERSE

INFLUENZA A VIRUS A/DARWIN/9/2021 SAN-010 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED)

KJA387FHB2

Status:

Possibly Marketed Outside US

Source:

BLA103914

(2013)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8213c229-a67a-4d3f-bd8f-b8729ae28472

First approved in 2013

Source:

BLA103914

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8213c229-a67a-4d3f-bd8f-b8729ae28472

Class:

STRUCTURALLY DIVERSE

INFLUENZA A VIRUS A/GUANGDONG-MAONAN/SWL1536/2019 CNIC-1909 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED)

NY1FF92M1E

Status:

Possibly Marketed Outside US

Source:

BLA103914

(2013)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8213c229-a67a-4d3f-bd8f-b8729ae28472

First approved in 2013

Source:

BLA103914

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8213c229-a67a-4d3f-bd8f-b8729ae28472

Class:

STRUCTURALLY DIVERSE

INFLUENZA A VIRUS A/HONG KONG/2671/2019 IVR-208 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED)

P8ORN3UOM6

Status:

Possibly Marketed Outside US

Source:

BLA103914

(2013)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8213c229-a67a-4d3f-bd8f-b8729ae28472

First approved in 2013

Source:

BLA103914

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8213c229-a67a-4d3f-bd8f-b8729ae28472

Class:

STRUCTURALLY DIVERSE

INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED)

VEH9U90EHX

Status:

Possibly Marketed Outside US

Source:

BLA103914

(2013)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8213c229-a67a-4d3f-bd8f-b8729ae28472

First approved in 2013

Source:

BLA103914

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8213c229-a67a-4d3f-bd8f-b8729ae28472

Class:

STRUCTURALLY DIVERSE

INFLUENZA B VIRUS B/MARYLAND/15/2016 BX-69A ANTIGEN (UV, FORMALDEHYDE INACTIVATED)

E7BK55UK8C

Status:

Possibly Marketed Outside US

Source:

BLA125163

(2013)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a9806027-8323-4abf-849f-46fb10984f13

First approved in 2013

Source:

BLA125163

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a9806027-8323-4abf-849f-46fb10984f13

Class:

STRUCTURALLY DIVERSE

INFLUENZA A VIRUS A/KANSAS/14/2017 X-327 (H3N2) ANTIGEN (UV, FORMALDEHYDE INACTIVATED)

IBB8KGB0WJ

Status:

Possibly Marketed Outside US

Source:

BLA125163

(2013)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a9806027-8323-4abf-849f-46fb10984f13

First approved in 2013

Source:

BLA125163

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a9806027-8323-4abf-849f-46fb10984f13

Class:

STRUCTURALLY DIVERSE

Nucleic Acid

MIPOMERSEN SODIUM

Structure of POLYQUATERNIUM-10 (20000 MPA.S AT 2%)

Polymer

POLYQUATERNIUM-10 (20000 MPA.S AT 2%)

Structurally Diverse

INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED)

Structurally Diverse

INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED)

Structurally Diverse

INFLUENZA A VIRUS A/DARWIN/9/2021 SAN-010 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED)

Structurally Diverse

INFLUENZA A VIRUS A/GUANGDONG-MAONAN/SWL1536/2019 CNIC-1909 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED)

Structurally Diverse

INFLUENZA A VIRUS A/HONG KONG/2671/2019 IVR-208 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED)

Structurally Diverse

INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED)

Structurally Diverse

INFLUENZA B VIRUS B/MARYLAND/15/2016 BX-69A ANTIGEN (UV, FORMALDEHYDE INACTIVATED)

Structurally Diverse

INFLUENZA A VIRUS A/KANSAS/14/2017 X-327 (H3N2) ANTIGEN (UV, FORMALDEHYDE INACTIVATED)

Showing 581 - 590 of 596 results

First page
Previous page
59
Next page
Next page

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1